About Open Pharma

Our workstreams

Open Pharma aims to improve the pharma publications model by connecting pharma with innovations in publishing to increase transparency and access to research outputs.

Transparency

Transparency

Includes open access trial transparency and data sharing

Aim: increase the access to scientific information to advance medical science and improve patient care

Accountability

Accountability

Includes authorship tools and DOIs for data, organizations and funders

Aim: increase accountability and transparency and reduce administrative burden

Accessibility

Accessibility

Includes preprints, plain language summaries and publication enhancements

Aim: faster and wider dissemination of results, increased citations and use of results

Discoverability

Discoverability

Includes metadata, information standardization and green open access

Aim: targeted content for each user group available for a single point

Members for 2021

astrazeneca-logo
galapagos-logo
gilead-logo
gsk-logo
nova-nordisk-logo
opg-logo
pfizer-logo
TAKEDA-LOGO

Supporters for 2021

alexion-logo
ipsen-logo
novartis-logo
roche-logo
ucb-logo
wiley-logo

The Open Pharma Team

Adeline Rosenberg

Adeline Rosenberg

Medical Writer

(more…)
Caitlin Edgell

Caitlin Edgell

Associate Medical Writer

(more…)
Chris Winchester

Chris Winchester

CEO of Oxford PharmaGenesis

(more…)
Francesca Ounsworth

Francesca Ounsworth

Account Executive

(more…)
Paul Farrow

Paul Farrow

Group Communications Director

(more…)
Sarah Sabir

Sarah Sabir

Senior Medical Writer

(more…)
Tanya Stezhka

Tanya Stezhka

Senior Account Manager

(more…)
Tim Koder

Tim Koder

Communications Director

(more…)
Tom Rees

Tom Rees

Communications Director

(more…)
Zoe Watts

Zoe Watts

Account Manager

(more…)